{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:06:09Z","timestamp":1774400769708,"version":"3.50.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Human T-cell leukemia virus type-1 (HTLV-1) establishes a long-term persistent infection in humans and causes malignant T-cell leukemia, adult T-cell leukemia (ATL). HTLV-1-specific cytotoxic T lymphocytes have been suggested to play a major role in the immunosurveillance of HTLV-1-infected T cells. However, it remains unclear whether HTLV-1-specific functional antibodies are also involved in the host defense. To explore the role of antibodies in the course of HTLV-1 infection, we quantitated HTLV-1-specific neutralizing and antibody-dependent cellular cytotoxicity (ADCC)-inducing antibody levels in plasma from asymptomatic carriers (ACs) and ATL patients. The levels of neutralizing antibodies, as determined by a syncytium inhibition assay, were significantly lower in acute and chronic ATL patients than in ACs. The levels of ADCC-inducing activity were tested using an autologous pair of HTLV-1-producing cells and cultured natural killer (NK) cells, which showed that the ADCC-inducing activity of IgG at a concentration of 100 \u00b5g\/ml was comparable between ACs and acute ATL patients. The anti-gp46 antibody IgG levels, determined by ELISA, correlated with those of the neutralizing and ADCC-inducing antibodies. In contrast, the proviral loads did not correlate with any of these antibody levels. NK cells and a monoclonal anti-gp46 antibody reduced the number of HTLV-1 Tax-expressing cells in cultured peripheral blood mononuclear cells from patients with aggressive ATL. These results suggest a protective role for HTLV-1 neutralizing and ADCC-inducing antibodies during the course of HTLV-1 infection.<\/jats:p>","DOI":"10.3389\/fimmu.2022.921606","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T07:56:35Z","timestamp":1663055795000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL)"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuetsu","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junnosuke","family":"Uchihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuiku","family":"Ohshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Masuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0736-4679(99)00173-0","article-title":"Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I)","volume":"18","author":"Edlich","year":"2000","journal-title":"J Emerg Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009915","article-title":"Very high prevalence of infection with the human T cell leukaemia virus type 1c in remote Australian aboriginal communities: Results of a large cross-sectional community survey","volume":"15","author":"Einsiedel","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1080115","article-title":"Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton","volume":"299","author":"Igakura","year":"2003","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158001","article-title":"HTLV-1 infection and pathogenesis: New insights from cellular and animal models","volume":"22","author":"Forlani","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(20000201)85:3<319::aid-ijc4>3.0.co;2-b","article-title":"Evaluation of adult T-cell leukemia\/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan","volume":"85","author":"Arisawa","year":"2000","journal-title":"Int J Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0272","article-title":"Human T-cell leukaemia virus type 1: Parasitism and pathogenesis","volume":"372","author":"Bangham","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.15.4780","article-title":"Healthy carriers of a human retrovirus, adult T-cell leukemia virus (ATLV): Demonstration by clonal culture of ATLV-carrying T cells from peripheral blood","volume":"79","author":"Gotoh","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","article-title":"Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes","volume":"95","author":"Hanon","year":"2000","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Gon\u00e7alves","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.4.2288-2295.1992","article-title":"Low degree of human T-cell leukemia\/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations","volume":"66","author":"Gessain","year":"1992","journal-title":"J Virol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","article-title":"Human T cell leukemia virus type 1: Persistence and pathogenesis","volume":"36","author":"Bangham","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.149.3.940","article-title":"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1","volume":"149","author":"Kuroki","year":"1992","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2013.0214","article-title":"Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46","volume":"30","author":"Tanaka","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/v8020041","article-title":"A potential of an anti-HTLV-I gp46 neutralizing monoclonal antibody (LAT-27) for passive immunization against both horizontal and mother-to-Child vertical infection with human T cell leukemia virus type-I","volume":"8","author":"Fujii","year":"2016","journal-title":"Viruses"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1992.8.227","article-title":"An antigenic structure of the trans-activator protein encoded by human T-cell leukemia virus type-I (HTLV-I), as defined by a panel of monoclonal antibodies","volume":"8","author":"Tanaka","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.2005.00698.x","article-title":"Proviral status of HTLV-1 integrated into the host genomic DNA of adult T-cell leukemia cells","volume":"27","author":"Kamihira","year":"2005","journal-title":"Clin Lab Haematol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9020082","article-title":"Conservation of a neutralization epitope of human T-cell leukemia virus type 1 (HTLV-1) among currently endemic clinical isolates in Okinawa, Japan","volume":"9","author":"Mizuguchi","year":"2020","journal-title":"Pathogens"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J Neurovirol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20807","article-title":"Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers","volume":"79","author":"Akimoto","year":"2007","journal-title":"J Med Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24802","article-title":"Analysis of HTLV-1 proviral load (PVL) and antibody detected with various kinds of tests in Japanese blood donors to understand the relationship between PVL and antibody level and to gain insights toward better antibody testing","volume":"89","author":"Matsumoto","year":"2017","journal-title":"J Med Virol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.3.716","article-title":"Neutralizing activity and antibody reactivity toward immunogenic regions of the human T cell leukemia virus type I surface glycoprotein in sera of infected patients with different clinical states","volume":"175","author":"Astier-Gin","year":"1997","journal-title":"J Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/v14040751","article-title":"Elevation of the plasma levels of TNF receptor 2 in association with those of CD25, OX40, and IL-10 and HTLV-1 proviral load in acute adult T-cell leukemia","volume":"14","author":"Kato","year":"2022","journal-title":"Viruses"},{"key":"B25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00280-016-3070-2","article-title":"Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma","volume":"78","author":"Ogura","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-014-0116-6","article-title":"Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of tax expression","volume":"11","author":"Rowan","year":"2014","journal-title":"Retrovirology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v97.10.3177","article-title":"Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state","volume":"97","author":"Yasunaga","year":"2001","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/943867","article-title":"Opportunistic infections in patients with HTLV-1 infection","volume":"2015","author":"Tanaka","year":"2015","journal-title":"Case Rep Hematol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.812016","article-title":"HTLV-1 and Co-infections","volume":"9","author":"Rosadas","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: A nationwide prospective study in Japan","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-5-96","article-title":"Anti-HTLV antibody profiling reveals an antibody signature for HTLV-i-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"5","author":"Burbelo","year":"2008","journal-title":"Retrovirology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-19","article-title":"Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals","volume":"10","author":"Enose-Akahata","year":"2013","journal-title":"Retrovirology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-016-0263-z","article-title":"Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status","volume":"13","author":"Shiohama","year":"2016","journal-title":"Retrovirology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.celrep.2019.09.016","article-title":"The nature of the HTLV-1 provirus in naturally infected individuals analyzed by the viral DNA-Capture-Seq approach","volume":"29","author":"Katsuya","year":"2019","journal-title":"Cell Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910330302","article-title":"In vitro antibody-dependent cellular cytotoxicity against human T-cell leukemia\/lymphoma virus (HTLV)-producing cells","volume":"33","author":"Miyakoshi","year":"1984","journal-title":"Int J Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003053","article-title":"Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study","volume":"4","author":"Yonekura","year":"2020","journal-title":"Blood Adv"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.921606\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T22:05:00Z","timestamp":1676757900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.921606\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2022.921606"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.921606","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,13]]},"article-number":"921606"}}